News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
PharmaDrug Announces Issuance of Debenture Units
November 15, 2024
·
5 min read
Press Releases
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
November 15, 2024
·
4 min read
Press Releases
Defence Therapeutics Announces Securities for Debenture Financing
November 15, 2024
·
5 min read
Press Releases
Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
November 14, 2024
·
9 min read
Press Releases
Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders
November 14, 2024
·
1 min read
Press Releases
NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates
November 14, 2024
·
11 min read
Press Releases
Adaptimmune Reports Q3 2024 Financial and Business Updates
November 13, 2024
·
16 min read
Press Releases
Adaptimmune’s Lete-cel Achieves Primary Endpoint in Pivotal Trial
November 13, 2024
·
8 min read
Press Releases
PreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints President
November 13, 2024
·
4 min read
Press Releases
Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors
November 13, 2024
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us